Repatha Now Approved Sep 11, 2015Sep 25, 2015 Brand: Repatha (evolocumab), Injection Parent Company: Amgen Drug Type: Prescription Drug Category: Cardiovascular Campaign: now-approved Targeting: HCPs, Patients Patient Website: https://www.repatha.com/ HCP Website: https://www.repathahcp.com/ Patient Now Approved Initial Page Patient Now Approved Homepage Patient Now Approved Homepage on Mobile Patient Now Approved Level 2 Page HCP Now Approved Homepage